Vor Biopharma Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript
Good afternoon, everybody. Welcome to our fireside with Vor. We've got Nate and Tirtha with us here today. Thanks so much for joining us, guys. I look forward to a productive talk, hopefully you've had a good conference so far.
Let's get started with the news that it is, which was VOR33 data, which we'd expected some initial data out of your additive transplant graft source this year. But you also said this week that we're going to see some follow-up data with Mylotarg. Can you give us a little bit more color, maybe on exactly what we'll get this year -- how many patients, how much follow-up -- that sort of things?
And if I may, also just -- can you just [bowler gang start] because as some folks are still learning about Vor, just remind folks why this is a different way of doing transplant, maybe just a quick 30-second at the start of that.
Okay. Well, I'll kick it off. Thanks for having us here, both Tirth and I. We're very excited to be here. So the whole concept of Vor takes gene
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
